Table 1.
Characteristics of patients participating in the clinical testing stage.
| Characteristics | Mean ± SD or % (N) |
|---|---|
| Sex | |
| Male | 53.3% (8) |
| Female | 46.7% (7) |
| Age (years) | 62.4 ± 16.5 |
| Diagnosis | |
| Cardiac | 13.3% (2) |
| Neuro | 13.3% (2) |
| Respiratory | 37.5% (6) |
| Surgical | 26.7% (4) |
| Urogenital | 6.7% (1) |
| COVID + | 6.7% (1) |
| APACHE II (points) | 24.5 ± 7.9 |
| Predicted mortality (%) | 45.7 ± 21.6 |
| RASS score | −1.9 ± 1.9 |
| PEEP (cmH2O) | 8.0 ± 0.2 |
| Inspiratory pressure (cmH2O) | 23.9 ± 0.3 |
| FiO2(%) | 30 ± 0.8 |
APACHE II: acute physiology and chronic health evaluation II score, FiO2: fraction of inspired oxygen, RASS: Richmond agitation sedation scale.